Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27287856

Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Neurooncol
Publication date
2016 Aug
First author
Jakacki RI

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Jakacki RI
      type
      Author
    2. name
      Foley MA
      type
      Author
    3. name
      Horan J
      type
      Author
    4. name
      Wang J
      type
      Author
    5. name
      Kieran MW
      type
      Author
    6. name
      Bowers DC
      type
      Author
    7. name
      Bouffet E
      type
      Author
    8. name
      Zacharoulis S
      type
      Author
    9. name
      Gill SC
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Jakacki RI
      type
      Author
    2. name
      Foley MA
      type
      Author
    3. name
      Horan J
      type
      Author
    4. name
      Wang J
      type
      Author
    5. name
      Kieran MW
      type
      Author
    6. name
      Bowers DC
      type
      Author
    7. name
      Bouffet E
      type
      Author
    8. name
      Zacharoulis S
      type
      Author
    9. name
      Gill SC
      type
      Author
    bibliography ids
    1. nci-bib-2d79aedd630e9127dfe688c2
    book metadata
    content sha256
    eba8d663b9e77898c205ab22577e1ff5b4c716699159e4acd9c44c84bcac2ac0
    document type
    citation
    dois
    1. 10.1007/s11060-016-2155-4
    electronic publication date
    display
    2016 Jun 10
    precision
    day
    year
    2016
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:27287856
    immutable id
    pubmed:27287856@eba8d663b9e77898c205ab22577e1ff5b4c716699159e4acd9c44c84bcac2ac0
    journal
    abbreviation
    J Neurooncol
    issn electronic
    1573-7373
    issn print
    0167-594X
    issue
    1
    name
    Journal of neuro-oncology
    nlm unique id
    8309335
    pages
    131-8
    volume
    129
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      27287856
      provenance
      batch id
      fe5a46c92522c34737e8
      provider
      NCBI PubMed ESummary
      record sha256
      f9781d7366345d33469de7f63eb21dd4519ac711ee28b89644e01d008ee3b535
      response sha256
      2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
      retrieved at
      2026-09-09T23:47:17.939307+00:00
      publication date
      display
      2016 Aug
      precision
      month
      year
      2016
      publication types
      1. Journal Article
      2. Multicenter Study
      3. Randomized Controlled Trial
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/27287856/
      title
      Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study.

      Preserved source evidence · Not medical advice